Skip to main content
Top
Published in: Journal of General Internal Medicine 4/2008

01-04-2008 | Original Article

Impact of Computerized Decision Support on Blood Pressure Management and Control: A Randomized Controlled Trial

Authors: LeRoi S. Hicks, MD, MPH, Thomas D. Sequist, MD, MPH, John Z. Ayanian, MD, MPP, Shimon Shaykevich, MS, David G. Fairchild, MD, MPH, E. John Orav, Ph.D., David W. Bates, MD, MSc

Published in: Journal of General Internal Medicine | Issue 4/2008

Login to get access

Abstract

BACKGROUND

We conducted a cluster randomized controlled trial to examine the effectiveness of computerized decision support (CDS) designed to improve hypertension care and outcomes in a racially diverse sample of primary care patients.

METHODS

We randomized 2,027 adult patients receiving hypertension care in 14 primary care practices to either 18 months of their physicians receiving CDS for each hypertensive patient or to usual care without computerized support for the control group. We assessed prescribing of guideline-recommended drug therapy and levels of blood pressure control for patients in each group and examined if the effects of the intervention differed by patients’ race/ethnicity using interaction terms.

MEASUREMENTS AND MAIN RESULTS

Rates of blood pressure control were 42% at baseline and 46% at the outcome visit with no significant differences between groups. After adjustment for patients’ demographic and clinical characteristics, number of prior visits, and levels of baseline blood pressure control, there were no differences between intervention groups in the odds of outcome blood pressure control. The use of CDS to providers significantly improved Joint National Committee (JNC) guideline adherent medication prescribing compared to usual care (7% versus 5%, P < 0.001); the effects of the intervention remained after multivariable adjustment (odds ratio [OR] 1.39 [CI, 1.13–1.72]) and the effects of the intervention did not differ by patients’ race and ethnicity.

CONCLUSIONS

CDS improved appropriate medication prescribing with no improvement in disparities in care and overall blood pressure control. Future work focusing on improvement of these interventions and the study of other practical interventions to reduce disparities in hypertension-related outcomes is needed.
Appendix
Available only for authorised users
Literature
1.
go back to reference Anonymous. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413–46.CrossRef Anonymous. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413–46.CrossRef
2.
go back to reference Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957–63.PubMedCrossRef Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957–63.PubMedCrossRef
3.
go back to reference Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med. 2000;160:2281–6.PubMedCrossRef Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med. 2000;160:2281–6.PubMedCrossRef
4.
go back to reference Oliveria SA, Lapuerta P, McCarthy BD, L’Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002;162:413–20.PubMedCrossRef Oliveria SA, Lapuerta P, McCarthy BD, L’Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002;162:413–20.PubMedCrossRef
5.
go back to reference Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA. 2003;290:199–206.PubMedCrossRef Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA. 2003;290:199–206.PubMedCrossRef
6.
go back to reference Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–72.PubMedCrossRef Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–72.PubMedCrossRef
7.
go back to reference Sundquist J, Winkleby MA, Pudaric S. Cardiovascular disease risk factors among older black, Mexican-American, and white women and men: an analysis of NHANES III, 1988–1994. Third National Health and Nutrition Examination Survey. J Am Geriatr Soc. 2001;49:109–16.PubMedCrossRef Sundquist J, Winkleby MA, Pudaric S. Cardiovascular disease risk factors among older black, Mexican-American, and white women and men: an analysis of NHANES III, 1988–1994. Third National Health and Nutrition Examination Survey. J Am Geriatr Soc. 2001;49:109–16.PubMedCrossRef
8.
go back to reference Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479–86.PubMedCrossRef Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479–86.PubMedCrossRef
9.
go back to reference Materson BJ. Lessons on the interaction of race and anti-hypertensive drugs from the VA cooperative study group on anti-hypertensive agents. Am J Hypertension. 1995;8:91s–3s.CrossRef Materson BJ. Lessons on the interaction of race and anti-hypertensive drugs from the VA cooperative study group on anti-hypertensive agents. Am J Hypertension. 1995;8:91s–3s.CrossRef
10.
go back to reference Richardson AD, Piepho RW. Effect of race on hypertension and anti-hypertensive therapy. Int J Clin Pharmacol Ther. 2000;38:75–9.PubMed Richardson AD, Piepho RW. Effect of race on hypertension and anti-hypertensive therapy. Int J Clin Pharmacol Ther. 2000;38:75–9.PubMed
11.
go back to reference He J, Klag MJ, Caballero B, Appel LJ, Charleston J, Whelton PK. Plasma insulin levels and incidence of hypertension in African Americans and Whites. Arch Intern Med. 1999;159:498–503.PubMedCrossRef He J, Klag MJ, Caballero B, Appel LJ, Charleston J, Whelton PK. Plasma insulin levels and incidence of hypertension in African Americans and Whites. Arch Intern Med. 1999;159:498–503.PubMedCrossRef
12.
go back to reference Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribution of major diseases to disparities in mortality. N Engl J Med. 2002;347:1585–92.PubMedCrossRef Wong MD, Shapiro MF, Boscardin WJ, Ettner SL. Contribution of major diseases to disparities in mortality. N Engl J Med. 2002;347:1585–92.PubMedCrossRef
13.
go back to reference Hyman DJ, Pavlik VN. Uncontrolled hypertension as a risk for coronary artery disease: patient characteristics and the role of physician intervention. Diabetes Care. 2003;26:355–9.CrossRef Hyman DJ, Pavlik VN. Uncontrolled hypertension as a risk for coronary artery disease: patient characteristics and the role of physician intervention. Diabetes Care. 2003;26:355–9.CrossRef
14.
go back to reference Hicks LS, Fairchild DG, Horng MS, Orav EJ, Bates DW, Ayanian JZ. Determinants of JNC VI guideline adherence, intensity of drug therapy, and blood pressure control by race and ethnicity. Hypertension. 2004;44:429–34.PubMedCrossRef Hicks LS, Fairchild DG, Horng MS, Orav EJ, Bates DW, Ayanian JZ. Determinants of JNC VI guideline adherence, intensity of drug therapy, and blood pressure control by race and ethnicity. Hypertension. 2004;44:429–34.PubMedCrossRef
15.
go back to reference Cooper LA, Hill MN, Powe N. Designing and evaluating interventions to eliminate racial and ethnic disparities in health care. J Gen Intern Med. 2002;17:477–86.PubMedCrossRef Cooper LA, Hill MN, Powe N. Designing and evaluating interventions to eliminate racial and ethnic disparities in health care. J Gen Intern Med. 2002;17:477–86.PubMedCrossRef
16.
go back to reference Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington: National Academy Press; 2003. Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington: National Academy Press; 2003.
17.
go back to reference Groman R, Ginsburg J, for the American College of Physicians. Racial and ethnic disparities in health care: a position paper of the American College of Physicians. Ann Intern Med. 2004;141:226–32.PubMed Groman R, Ginsburg J, for the American College of Physicians. Racial and ethnic disparities in health care: a position paper of the American College of Physicians. Ann Intern Med. 2004;141:226–32.PubMed
18.
go back to reference Sequist TD, Gandhi TK, Karson AS, et al. A randomized trial of electronic clinical reminders to improve quality of care for diabetes and coronary artery disease. J Am Med Inform Assoc. 2005;12:431–7.PubMedCrossRef Sequist TD, Gandhi TK, Karson AS, et al. A randomized trial of electronic clinical reminders to improve quality of care for diabetes and coronary artery disease. J Am Med Inform Assoc. 2005;12:431–7.PubMedCrossRef
19.
go back to reference Garg AX, Adhikari NK, McDonald H, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes. A systematic review. JAMA. 2005;293:1223–38.PubMedCrossRef Garg AX, Adhikari NK, McDonald H, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes. A systematic review. JAMA. 2005;293:1223–38.PubMedCrossRef
20.
go back to reference Tierney WM, Overhage JM, Murray MD, et al. Effects of computerized guidelines for managing heart disease in primary care. J Gen Intern Med. 2003;18:967–76.PubMedCrossRef Tierney WM, Overhage JM, Murray MD, et al. Effects of computerized guidelines for managing heart disease in primary care. J Gen Intern Med. 2003;18:967–76.PubMedCrossRef
21.
go back to reference Nilasena DS, Lincoln MJ. A computer-generated reminder system improves physician compliance with diabetes preventive care guidelines. Proc Annu Symp Comput Appl Med Care. 1995;640–5. Nilasena DS, Lincoln MJ. A computer-generated reminder system improves physician compliance with diabetes preventive care guidelines. Proc Annu Symp Comput Appl Med Care. 1995;640–5.
22.
go back to reference Hunt DL, Haynes RB, Hanna SE, Smith K. Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review. JAMA. 1998;280:1339–46.PubMedCrossRef Hunt DL, Haynes RB, Hanna SE, Smith K. Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review. JAMA. 1998;280:1339–46.PubMedCrossRef
23.
go back to reference Shea S, DuMouchel W, Bahamonde L. A meta-analysis of 16 randomized controlled trials to evaluate computer-based clinical reminder systems for preventive care in the ambulatory setting. J Am Med Inform Assoc. 1996;3:399–409.PubMed Shea S, DuMouchel W, Bahamonde L. A meta-analysis of 16 randomized controlled trials to evaluate computer-based clinical reminder systems for preventive care in the ambulatory setting. J Am Med Inform Assoc. 1996;3:399–409.PubMed
24.
go back to reference Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290:1624–32.PubMedCrossRef Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290:1624–32.PubMedCrossRef
25.
go back to reference Smith SC Jr, Blair SN, Bonow RO, et al. AHA/ACC scientific statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 2001;104:1577–79.PubMedCrossRef Smith SC Jr, Blair SN, Bonow RO, et al. AHA/ACC scientific statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 2001;104:1577–79.PubMedCrossRef
26.
go back to reference Quality compass 2003. Washington, DC: National Committee for Quality Assurance, 2003 (computer disk). Quality compass 2003. Washington, DC: National Committee for Quality Assurance, 2003 (computer disk).
27.
go back to reference Frane J. SUDAAN: Professional Software for Survey Data Analysis. Research Triangle Park, NC: Research Triangle Institute; 1989. Frane J. SUDAAN: Professional Software for Survey Data Analysis. Research Triangle Park, NC: Research Triangle Institute; 1989.
28.
go back to reference Forrest CB, Whelan EM. Primary care safety-net delivery sites in the United States: a comparison of community health centers, hospital outpatient departments, and physicians’ offices. JAMA. 2000;284:2077–83.PubMedCrossRef Forrest CB, Whelan EM. Primary care safety-net delivery sites in the United States: a comparison of community health centers, hospital outpatient departments, and physicians’ offices. JAMA. 2000;284:2077–83.PubMedCrossRef
29.
go back to reference Hicks LS, Shaykevich S, Bates DW, Ayanian JZ. Determinants of racial/ethnic differences in blood pressure management among hypertensive patients. BMC Cardiovasc Disord. 2005;5:16.PubMedCrossRef Hicks LS, Shaykevich S, Bates DW, Ayanian JZ. Determinants of racial/ethnic differences in blood pressure management among hypertensive patients. BMC Cardiovasc Disord. 2005;5:16.PubMedCrossRef
30.
go back to reference Gerber JC, Stewart DL. Prevention and control of hypertension and diabetes in an underserved population through community outreach and disease management: a plan of action. J Assoc Acad Minor Physicians. 1998;9:48–52. Gerber JC, Stewart DL. Prevention and control of hypertension and diabetes in an underserved population through community outreach and disease management: a plan of action. J Assoc Acad Minor Physicians. 1998;9:48–52.
31.
go back to reference Kottke TE, Stroebel RJ, Hoffman RS. JNC 7—it’s more than high blood pressure. JAMA. 2003;289:2573–5.PubMedCrossRef Kottke TE, Stroebel RJ, Hoffman RS. JNC 7—it’s more than high blood pressure. JAMA. 2003;289:2573–5.PubMedCrossRef
32.
go back to reference Luck J, Peabody JW, Dresselhaus TR, Lee M, Glassman P. How well does chart abstraction measure quality? A prospective comparison of standardized patients with the medical record. Am J Med. 2000;108:642–9.PubMedCrossRef Luck J, Peabody JW, Dresselhaus TR, Lee M, Glassman P. How well does chart abstraction measure quality? A prospective comparison of standardized patients with the medical record. Am J Med. 2000;108:642–9.PubMedCrossRef
Metadata
Title
Impact of Computerized Decision Support on Blood Pressure Management and Control: A Randomized Controlled Trial
Authors
LeRoi S. Hicks, MD, MPH
Thomas D. Sequist, MD, MPH
John Z. Ayanian, MD, MPP
Shimon Shaykevich, MS
David G. Fairchild, MD, MPH
E. John Orav, Ph.D.
David W. Bates, MD, MSc
Publication date
01-04-2008
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 4/2008
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0403-1

Other articles of this Issue 4/2008

Journal of General Internal Medicine 4/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.